Dag Andersson

Dag Andersson has a diverse work experience that spans several industries. Dag is currently serving as the Chief Executive Officer at XVIVO Perfusion AB, a medical technology company specializing in organ preservation. Prior to this, they held positions as a Member of the Board of Directors at Terveystalo, GHP Specialty Care AB, and Nolato. From 2008 to 2018, Dag Andersson served as the Chief Executive Officer of Diaverum, a global healthcare service company. Dag also held various leadership roles at Mölnlycke, including President and Managing Director for the UK and EMEA markets. In these positions, they gained experience in operational management, sales, marketing, and integration of acquired companies.

Dag Andersson's education history is as follows:

- From 1987 to 1988, they attended INSEAD and obtained an MBA degree in the field of study of MBA.

- Between 1983 and 1985, they studied at Uppsala University, focusing on Russian and Eastern European Economics.

- From 1981 to 1985, they pursued a Bachelor of Science (BS) degree in Business Administration and Management, General at Stockholm School of Economics.

- In 1983 and 1984, they attended the Swedish defence language school (Tolkskolan) to study Russian and Eastern European Studies.